Model Legislation

New NASHP Model Legislation Helps States Bring Transparency to Pharmacy Benefit Managers

The National Academy for State Health Policy (NASHP) has released model legislation to help states shed light on the opaque business practices of pharmacy benefit managers (PBMs). States can use the model bill to require the licensing of PBMs, ban gag clauses that prevent pharmacists from sharing lower-price drug options with consumers, and require more […]

Read More
  • Pharmacy Benefit Manager Model Legislation: Questions and Answers

    These questions and answers explain the role pharmacy benefit managers (PBM) play in the drug supply chain and highlight NASHP’s model PBM legislation that states can use to better oversee PBMs and protect consumers. What are pharmacy benefit managers? Pharmacy benefit managers (PBMs) contract with health plans to administer their pharmacy benefits. Depending what a health […]

    Read More
  • A Glossary of All Terms Pharma

    If you’re working to control the cost of prescription drugs, you need to know the lingo used by the pharmaceutical industry. Below is a glossary of terms commonly used by players in the drug research, regulation, manufacturing, distribution, and purchasing worlds. Drug Product Terms Brand product: Branded products are not generic drugs or products. A brand can be […]

    Read More
  • Vermont First in the Nation to Approve Rx Drug Importation from Canada

    Vermont is the first state  in the nation to approve importation of less-costly prescription drugs from Canada. For the first time in the United States, obtaining low-cost prescription drugs from Canada is one step closer to reality today following the Vermont state legislature’s landmark enactment of S.175. Vermont Gov. Philip Scott signed the bill into law on […]

    Read More
  • Maryland Lawmakers Submit Drug Cost Review Bill Based on NASHP’s Model Legislation
    State Health Policy Blog

    ANNAPOLIS — State lawmakers are scheduled to introduce a bill today that empowers Maryland to regulate prescription drug costs by evaluating the affordability of certain drugs and imposing limits on what the state and commercial health plans will pay them. Based on model legislation created by the National Academy for State Health Policy (NASHP), the […]

    Read More
  • Utah State Legislator Introduces Bill to Import Prescription Drugs from Canada, Based on NASHP Model Legislation

    Salt Lake City, Utah: Today, Republican state legislator Norman Thurston introduced groundbreaking legislation to create a safe, state-run prescription drug importation program that would import high-cost drugs from Canada, where prescription drugs cost 30 percent less than in the United States. The proposal for a whole-sale importation program of select, higher-cost drugs that are already […]

    Read More
  • State Health Policy Blog

    States are searching for new and innovative approaches to handle the rising cost of prescription medicines – both the sudden spike in spending that comes with a new high-cost treatment and the ongoing challenges of regular, inexplicable, price hikes for all covered drugs. The United States has the highest prescription drug prices in the world. […]

    Read More
  • Publications

    Because the federal government has not been able to agree on an approach to constrain prescription drug prices, states need to address the problem. Study after study show how U.S. consumers pay the highest prices in the world for life-saving and life-enhancing drug treatments. The prices we pay may fund the research and development that […]

    Read More
  • Pharmaceutical prices are rising, driving up premiums and out of pocket costs. State budgets – that by law, have to be balanced– are reeling from high and unpredictable pharmaceutical price increases for Corrections, state employees and retirees, K-12 and public  university employees, and, of course,  Medicaid. To address rapidly rising prescription drug prices, purchasers and policy […]

    Read More
  • State Health Policy Blog

    Pharmaceutical prices are rising, driving up premiums and out-of-pocket costs. Today, 21 percent of spending in employer-sponsored plans goes to retail prescription drugs.[i] State budgets – which by law must be balanced- are reeling from high and unpredictable pharmaceutical increases for corrections, state employees and retirees, K-12 and public university employees, and, of course, Medicaid. […]

    Read More